Skip to Main Content

Fighting Cardiovascular Diseases With In Silico Solutions

Computational modeling and simulation (CM&S) of cardiovascular devices and their working environment — the human body and heart — is the most promising way to accelerate and amplify medical innovation while limiting the risk for the patients through in silico research, in silico testing, and in silico clinical trials. 

Ansys simulations go beyond an advanced cardiovascular system model by using multiscale, multiphysics simulations in a suite of connected tools to provide a complete and pragmatic solution.

Optimize Cardiovascular Devices Through Simulation

With more than 30 percent of all deaths attributed to cardiovascular diseases, the healthcare industry invests massively in disease prevention, treatment, and efforts to shorten the recovery period. The extensive in vitro and in vivo testing required to ensure patient safety inevitably slows the delivery of innovative implantable cardiovascular devices — stents, valves, or pacemakers/defibrillators — to those who need them the most.  Leveraging the power of in silico medicine and developing a detailed and reliable multiphysics model of the device and its working environment (the human body) provides the necessary insights to test and optimize new products, help accelerate regulatory approval, and save lives.

 

Webinars

Learn more about the work that is being done in the Cardiovascular space at Ansys.

Success Stories and Thought Leadership

Learn how our collegues, customers, and partners around the world are using simulation to advance cardiovascular medical devices. 

Available E-Books

og-in-silico-cardiovascular-ebook.png

Fighting Cardiovascular Diseases With in silico Solutions

With cardiovascular diseases causing over 30% of deaths, the healthcare industry invests heavily in prevention, treatment, and faster recovery. Extensive in vitro and in vivo testing delays the delivery of life-saving implantable devices like stents, valves, and pacemakers. in silico medicine, through detailed multiphysics modeling, offers critical insights to optimize designs, accelerate regulatory approval, and save lives.

cardio-campaign-passive-implants-e-book-og.jpg

Overcoming Passive Cardiovascular Device Challenges with Computational Modeling and Simulation

While passive cardiovascular implants may appear simple, their development, manufacturing, and implantation are complex. Delays in production and regulatory approval can postpone patient access to these lifesaving devices. Computational modeling and simulation (CM&S) help overcome these challenges by accelerating development, streamlining approval, and ensuring safety.

og-digital-twin-heart.jpg

Paving the Way Toward Connected Cardiac Digital Twins

The one-size-fits-all approach to healthcare is no longer a viable solution, as it fails to recognize the significant differences between individual patients. Digital twins and other advanced technologies are poised to speed up patient recovery and improve quality of life for people around the world, with a significant paradigm shift and new technology tool kits collecting and creating data for customized treatment.

Ansys Advantage Magazine 2024 Issue I: Simulation Transforms Healthcare

Visit Us at Our Upcoming Events

Making a Change Together

Ansys showcases how advanced cardiovascular simulation—from heart valve modeling to total artificial heart development—accelerates innovation and improves patient outcomes. By reducing development timelines, minimizing animal testing, and enhancing device safety, Ansys underscores its commitment to partnering with the medical community to advance the next generation of cardiovascular therapies.

Industry Leading Speakers

Ansys experts are frequently invited to leading cardiovascular conferences, where they share insights on simulation, biomedical engineering, and device design. From blood damage prediction to heart valve performance and artificial heart development, their thought leadership helps shape the future of medical device innovation and reinforces Ansys’ commitment to advancing safer, more effective therapies through collaboration with the medical community.

Mark Palmer presentation AMD 2025
Marc Horner presentation
md-m-west25-booth.jpg

Interested in Other Healthcare Applications?

Visit our healthcare industry page to learn about more healthcare applications that can benefit from modeling and simulation.